These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2297290)

  • 1. Fulminant hepatic failure associated with intravenous erythromycin lactobionate.
    Gholson CF; Warren GH
    Arch Intern Med; 1990 Jan; 150(1):215-6. PubMed ID: 2297290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythromycin-induced hypotension.
    Brown GR
    Ann Pharmacother; 1995 Sep; 29(9):934-5. PubMed ID: 8547744
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate.
    Keeffe EB; Reis TC; Berland JE
    Dig Dis Sci; 1982 Aug; 27(8):701-4. PubMed ID: 6980110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacokinetics of 1,000 mg erythromycin lactobionate i. v. in patients with respiratory tract infections (author's transl)].
    Sietzen W
    Infection; 1982; 10 Suppl 2():S99-101. PubMed ID: 7107025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic toxicity.
    Johnson AH
    J S C Med Assoc; 1971 Aug; 67(8):351-2. PubMed ID: 5286588
    [No Abstract]   [Full Text] [Related]  

  • 7. Telithromycin: new preparation. A needless addition to the other macrolides.
    Prescrire Int; 2003 Feb; 12(63):8-11. PubMed ID: 12602373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent with respiratory impairments and short-lived fever.
    Loose LM; Elde E; Aune MB; Vallersnes OM
    Tidsskr Nor Laegeforen; 2015 Jun; 135(12-13):1144-7. PubMed ID: 26130549
    [No Abstract]   [Full Text] [Related]  

  • 9. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatotoxic reaction to erythromycin ethylsuccinate.
    Patel J; Schneider R
    South Med J; 1984 Oct; 77(10):1343-4. PubMed ID: 6333077
    [No Abstract]   [Full Text] [Related]  

  • 11. Transient, selective factor X deficiency and acute liver failure following chest infection treated with erythromycin BP.
    Hosker JP; Jewell DP
    Postgrad Med J; 1983 Aug; 59(694):514-5. PubMed ID: 6622343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meropenem tolerance in a patient with probable fulminant piperacillin-induced immune hemolytic anemia.
    Prince BT; McMahon BJ; Jain M; Peters AT
    J Allergy Clin Immunol Pract; 2015; 3(3):452-3. PubMed ID: 25680924
    [No Abstract]   [Full Text] [Related]  

  • 13. Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.
    Coban S; Ceydilek B; Ekiz F; Erden E; Soykan I
    Ann Pharmacother; 2005 Oct; 39(10):1737-40. PubMed ID: 16105873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholestasis and liver cell damage due to hypersensitivity to erythromycin stearate--recurrence following therapy with erythromycin succinate.
    Horn S; Aglas F; Horina JH
    Wien Klin Wochenschr; 1999 Jan; 111(2):76-7. PubMed ID: 10081126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestatic hepatitis from erythromycin ethylsuccinate. Report of two cases.
    Diehl AM; Latham P; Boitnott JK; Mann J; Maddrey WC
    Am J Med; 1984 May; 76(5):931-4. PubMed ID: 6609640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythromycin-induced dynamic ileus?
    Heyman SN; Stalnikowicz R; Heyman A; Gilon D; Mogle P
    J Clin Gastroenterol; 1988 Oct; 10(5):551-4. PubMed ID: 3183328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of serum levels, venous irritation and gastrointestinal side-effects with intravenous erythromycin lactobionate in patients with bronchopulmonary infection.
    Marlin GE; Thompson PJ; Jenkins CR; Burgess KR; LaFranier DA
    Hum Toxicol; 1983 Oct; 2(4):593-605. PubMed ID: 6642516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of treatment with roxithromycin in comparison with erythromycin in patients with lower respiratory tract infections.
    Norinder A; Paulsen O; Hjortsberg C
    Scand J Infect Dis; 1997; 29(1):83-6. PubMed ID: 9112304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two oral forms of erythromycin in the treatment of acute respiratory tract infections. A multicentre general practice study.
    Macklin J; Barden R; Coles S
    J Int Med Res; 1989; 17(3):287-94. PubMed ID: 2670633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why use erythromycin?
    White RJ
    Thorax; 1994 Oct; 49(10):944-5. PubMed ID: 7974308
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.